CTRI/2024/04/065805
Not yet recruiting
Phase 1
Effectiveness of Cognitive Rehabilitation on Cognition and Quality of Life in Chemotherapy-Induced Cognitive Impairment- A Randomized Control Trial. - NI
Ravi Nair Physiotherapy College0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ravi Nair Physiotherapy College
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)Newly diagnosed patients with stages I to III cancers planning to receive a definitive number of platinum\-based compounds chemotherapy.
- •2\)Patients who are given Taxanes and Platinum\-based compounds – Cisplastin, Carboplatin and Oxaliplatin
- •3\)3\) Patients having Grade I or II cognitive impairment according to National Cancer Institute –common toxicity criteria.
- •4\)Planned to receive a minimum of 4 cycles of chemotherapy treatment with either of the chemotherapy agents (Platinum based compound)
- •5\)Both Male and female aged grouped between 14\-70 years.
- •6\)Patients who are given drugs according to approval of national cancer board
Exclusion Criteria
- •1\)Patients having Pre\-existing cognitive impairment.
- •2\)Patient having Traumatic Brain Injury.
- •3\)Patients having a previous history of any psychological condition that could impair cognitive function.
- •4\)Patients who did not perceive any chemotherapy cycle after cancer treatment.
- •5\)Patients with a previous history of cancer and chemotherapeutic drugs.
- •6\)Those who were having any neurological disorders in the brain and spinal cord such as Alzheimer’s disease (AD), Lewy body disease, stroke (CVA), Huntington’s disease, MS, ALS, frontotemporal dementia, and vascular dementia; use of medication known to have a negative impact on cognition (benzodiazepines).
- •7\)Use of antipsychotics and cholinesterase inhibitors (CHEIs); current or recent (past 6 months) alcohol or substance use disorder; any behavioural changes like depression, anxiety, stress, other systemic diseases likely to impair cognition, such as hypothyroidism, de ?ciency of folic acid or vitamin B12, or viral infection (syphilis, HIV); vision and speech impairment (aphasia).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of the effectiveness of cognitive rehabilitation on motor visual perception in dyslexic studentsIRCT20210609051522N1Fooman County Education Department30
Completed
Phase 2
Effectiveness of Cognitive Rehabilitation in Multiple Sclerosis.Dementia in other specified diseases classified elsewher.Dementia (in): cerebral lipidosis, epilepsy, hepatolenticular degeneration, hypercalcaemia, hypothyroidism, acquired, intoxications, multiple sclerosis, neurosyphilis, niacin deficiency, polyarteritis nodosa, systemic lupus erythematosus, trypanosomiasisIRCT2016090929714N1Vice chancellor for research, Shiraz University of Medical Sciences30
Recruiting
Not Applicable
The effect of cognitive rehabilitation based on information processing speed on occupational performance in people with Multiple SclerosisMultiple sclerosis.Multiple sclerosisIRCT20180517039699N1niversity of social welfare and rehabilitation sciences70
Completed
Not Applicable
Investigating the effect of cognitive rehabilitation on addiction treatmentDrug addiction.IRCT20230808059086N1Islamic Azad University30
Completed
Not Applicable
The Effectiveness of Cognitive Rehabilitation Therapy in SchizophreniaIRCT20210727052001N1niversity of social welfare and rehabilitation sciences30